Profiling bacteria in the lungs of patients with severe influenza versus COVID-19 with or without Aspergillosis
| dc.contributor.author | Feys, Simon | por |
| dc.contributor.author | Cardinali-Benigni, Martina | por |
| dc.contributor.author | Lauwers, Hanne Moon | por |
| dc.contributor.author | Jacobs, Cato | por |
| dc.contributor.author | Stevaert, Annelies | por |
| dc.contributor.author | Gonçalves, Samuel M | por |
| dc.contributor.author | Cunha, Cristina | por |
| dc.contributor.author | Debaveye, Yves | por |
| dc.contributor.author | Hermans, Greet | por |
| dc.contributor.author | Heylen, Jannes | por |
| dc.contributor.author | Humblet-Baron, Stephanie | por |
| dc.contributor.author | Lagrou, Katrien | por |
| dc.contributor.author | Maessen, Lenn | por |
| dc.contributor.author | Meersseman, Philippe | por |
| dc.contributor.author | Peetermans, Marijke | por |
| dc.contributor.author | Redondo-Rios, Alvaro | por |
| dc.contributor.author | Seldeslachts, Laura | por |
| dc.contributor.author | Starick, Marick R | por |
| dc.contributor.author | Thevissen, Karin | por |
| dc.contributor.author | Vande Velde, Greetje | por |
| dc.contributor.author | Vandenbriele, Christophe | por |
| dc.contributor.author | Vanderbeke, Lore | por |
| dc.contributor.author | Wilmer, Alexander | por |
| dc.contributor.author | Naesens, Lieve | por |
| dc.contributor.author | van de Veerdonk, Frank L | por |
| dc.contributor.author | Van Weyenbergh, Johan | por |
| dc.contributor.author | Gabaldón, Toni | por |
| dc.contributor.author | Wauters, Joost | por |
| dc.contributor.author | Carvalho, Agostinho | por |
| dc.date.accessioned | 2025-07-17T08:43:15Z | |
| dc.date.available | 2025-07-17T08:43:15Z | |
| dc.date.issued | 2024-11-15 | |
| dc.description | Data availability: All sequences were deposited in the NCBI Sequence Read Archive under the BioProject ID PRJNA1045644. Gene expression data used in this manuscript are available in the appendix of the publication in which these data were featured originally (Reference 12). The analytical codes for the 16S rRNA gene sequencing analyses are available under https://github.com/Gabaldonlab/lung_microbiome_16S. | por |
| dc.description.abstract | Rationale: The influence of the lung bacterial microbiome, including potential pathogens, in patients with influenza-associated pulmonary aspergillosis (IAPA) or coronavirus disease (COVID-19)-associated pulmonary aspergillosis (CAPA) has yet to be explored. Objectives: To explore the composition of the lung bacterial microbiome and its association with viral and fungal infection, immunity, and outcome in severe influenza versus COVID-19 with or without aspergillosis. Methods: We performed a retrospective study in mechanically ventilated patients with influenza and COVID-19 with or without invasive aspergillosis in whom BAL for bacterial culture (with or without PCR) was obtained within 2 weeks after ICU admission. In addition, 16S rRNA gene sequencing data and viral and bacterial load of BAL samples from a subset of these patients, and of patients requiring noninvasive ventilation, were analyzed. We integrated 16S rRNA gene sequencing data with existing immune parameter datasets. Measurements and Main Results: Potential bacterial pathogens were detected in 20% (28/142) of patients with influenza and 37% (104/281) of patients with COVID-19, whereas aspergillosis was detected in 38% (54/142) of patients with influenza and 31% (86/281) of patients with COVID-19. A significant association between bacterial pathogens in BAL fluid and 90-day mortality was found only in patients with influenza, particularly patients with IAPA. Patients with COVID-19, but not patients with influenza, showed increased proinflammatory pulmonary cytokine responses to bacterial pathogens. Conclusions: Aspergillosis is more frequently detected in the lungs of patients with severe influenza than bacterial pathogens. Detection of bacterial pathogens associates with worse outcome in patients with influenza, particularly in those with IAPA, but not in patients with COVID-19. The immunological dynamics of tripartite viral-fungal-bacterial interactions deserve further investigation. | por |
| dc.description.sponsorship | Supported by Fonds Wetenschappelijk Onderzoek grant G053121N (S.H.-B. and J.W.) and grants G0A0621N and G065421N (J.V.W.) and Ph.D. grants 11M6922N and 11M6924N (S.F.), 11PBR24N (J.H.), 1186121N and 1186123N (L.S.), and 11E9819N (L.V.); the Universitaire Ziekenhuizen Leuven, KU Leuven “Coronafonds” (J.W.); the Fundacão para a Ciência e a Tecnologia grants UIDB/50026/2020, UIDP/50026/2020, and PTDC/MED-OUT/1112/2021 (https://doi.org/10.54499/PTDC/MED-OUT/1112/2021) (A.C.), and 2022.06674.PTDC (https://doi.org/10. 54499/2022.06674.PTDC) and CEECIND/04058/2018 (https://doi.org/10.54499/CEECIND/04058/2018/CP1581/CT0015) (C.C.); the “la Caixa” Foundation under the agreement LCF/PR/HR22/52420003 (MICROFUN) (C.C.); and the European Union’s Horizon 2020 Framework Programme grant agreement number 847507 (Host-Directed Medicine in Invasive Fungal Infections) (F.L.v.d.V., A.C., and J.W.). For this research, the Toni Gabaldon group acknowledges support from the Ministerio de Ciencia e Innovacion for grants PID2021-126067NB-I00, CPP2021-008552, PCI2022-135066-2, and PDC2022-133266-I00, cofounded by ERDF “A way of making Europe”; the Agencia de Gestió d’Ajuts Universitaris i de Recerca grant SGR01551; European Union’s Horizon 2020 research and innovation programme grant ERC-2016-724173; Gordon and Betty Moore Foundation grant GBMF9742; “La Caixa” foundation grant LCF/PR/HR21/00737; and Instituto de Salud Carlos III grants IMP/00019 and CIBERINFEC CB21/13/00061-ISCIII-SGEFI/ERDF. | por |
| dc.distribution | international | por |
| dc.identifier.citation | Feys, S., Cardinali-Benigni, M., Lauwers, H. M., Jacobs, C., Stevaert, A., Gonçalves, S. M., Cunha, C., Debaveye, Y., Hermans, G., Heylen, J., Humblet-Baron, S., Lagrou, K., Maessen, L., Meersseman, P., Peetermans, M., Redondo-Rios, A., Seldeslachts, L., Starick, M. R., Thevissen, K., … Carvalho, A. (2024). Profiling Bacteria in the Lungs of Patients with Severe Influenza Versus COVID-19 with or without Aspergillosis. American Journal of Respiratory and Critical Care Medicine, 210(10), 1230–1242. https://doi.org/10.1164/rccm.202401-0145oc | por |
| dc.identifier.doi | 10.1164/rccm.202401-0145OC | por |
| dc.identifier.eissn | 1535-4970 | por |
| dc.identifier.issn | 1073-449X | por |
| dc.identifier.pmid | 38865563 | |
| dc.identifier.uri | https://hdl.handle.net/1822/96543 | |
| dc.language.iso | eng | por |
| dc.peerreviewed | yes | por |
| dc.publisher | American Thoracic Society | por |
| dc.relation | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F50026%2F2020/PT | por |
| dc.relation | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDP%2F50026%2F2020/PT | por |
| dc.relation | info:eu-repo/grantAgreement/FCT/3599-PPCDT/PTDC%2FMED-OUT%2F1112%2F2021/PT | por |
| dc.relation | info:eu-repo/grantAgreement/FCT/CEEC IND 2018/CEECIND%2F04058%2F2018%2FCP1581%2FCT0015/PT | por |
| dc.relation | info:eu-repo/grantAgreement/EC/H2020/847507/EU | por |
| dc.relation | info:eu-repo/grantAgreement/EC/H2020/724173/EU | por |
| dc.relation | 2022.06674.PTDC | por |
| dc.relation | info:eu-repo/grantAgreement/FCT/CEEC IND 2018/CEECIND%2F04058%2F2018%2FCP1581%2FCT0015/PT | por |
| dc.relation.publisherversion | https://www.atsjournals.org/doi/10.1164/rccm.202401-0145OC | por |
| dc.rights | openAccess | por |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | por |
| dc.subject | Humans | por |
| dc.subject | Retrospective Studies | por |
| dc.subject | SARS-CoV-2 | por |
| dc.subject | Bronchoalveolar Lavage Fluid | por |
| dc.subject | RNA, Ribosomal, 16S | por |
| dc.subject | Microbiota | por |
| dc.subject | Pulmonary Aspergillosis | por |
| dc.subject | Coinfection | por |
| dc.subject | COVID-19 | por |
| dc.subject | Influenza, Human | por |
| dc.subject | Lung | por |
| dc.subject | aspergillosis | por |
| dc.subject | immunology | por |
| dc.subject | influenza | por |
| dc.subject | microbiome | por |
| dc.subject.fos | Ciências Médicas::Ciências da Saúde | por |
| dc.subject.ods | Saúde de qualidade | por |
| dc.title | Profiling bacteria in the lungs of patients with severe influenza versus COVID-19 with or without Aspergillosis | por |
| dc.type | article | eng |
| dspace.entity.type | Publication | en |
| oaire.citationEndPage | 1242 | por |
| oaire.citationIssue | 10 | por |
| oaire.citationStartPage | 1230 | por |
| oaire.citationVolume | 210 | por |
| oaire.version | VoR | por |
| sdum.journal | American Journal of Respiratory and Critical Care Medicine | por |
Ficheiros
Pacote original
1 - 1 de 1
A carregar...
- Nome:
- feys-et-al-2024-profiling-bacteria-in-the-lungs-of-patients-with-severe-influenza-versus-covid-19-with-or-without.pdf
- Tamanho:
- 1.35 MB
- Formato:
- Adobe Portable Document Format
- Descrição: